BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/16/2023 4:01:22 AM | Browse: 677 | Download: 1997
Publication Name World Journal of Clinical Cases
Manuscript ID 87917
Country China
Received
2023-09-25 07:27
Peer-Review Started
2023-09-25 07:27
First Decision by Editorial Office Director
2023-10-17 07:32
Return for Revision
2023-10-17 07:32
Revised
2023-10-18 08:23
Publication Fee Transferred
Second Decision by Editor
2023-10-30 00:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2023-11-02 08:29
Articles in Press
2023-11-02 08:29
Edit the Manuscript by Language Editor
2023-10-27 07:20
Typeset the Manuscript
2023-11-10 07:50
Publish the Manuscript Online
2023-11-16 04:01
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Randomized Clinical Trial
Article Title Efficacy and safety of aspirin antiplatelet therapy within 48 h of symptom onset in patients with acute stroke
Manuscript Source Unsolicited Manuscript
All Author List Jian-Quan Zhang and Zhi-Bin Pan
ORCID
Author(s) ORCID Number
Jian-Quan Zhang http://orcid.org/0009-0004-2225-5810
Funding Agency and Grant Number
Corresponding Author Jian-Quan Zhang, MSc, Associate Chief Physician, Department of Emergency Medicine, The First Affiliated Hospital of Jiangxi Medical College, No. 31 Qingfeng Road, Shangrao 334000, Jiangxi Province, China. tuju0931042072@126.com
Key Words Aspirin; Acute stroke; Antiplatelet therapy; Recurrent stroke; Recurrent vascular events; Myocardial infarction
Core Tip While aspirin use within 48 h of acute stroke showed improved functional outcomes, it did not significantly reduce the risk of recurrent vascular events compared to no aspirin. The safety profile of aspirin was acceptable and comparable to no aspirin. Further research with larger sample sizes and longer follow-up is required to validate these findings and determine the optimal timing and dose of aspirin initiation after an acute stroke.
Publish Date 2023-11-16 04:01
Citation Zhang JQ, Pan ZB. Efficacy and safety of aspirin antiplatelet therapy within 48 h of symptom onset in patients with acute stroke. World J Clin Cases 2023; 11(32): 7814-7821
URL https://www.wjgnet.com/2307-8960/full/v11/i32/7814.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i32.7814
Full Article (PDF) WJCC-11-7814-with-cover.pdf
Full Article (Word) WJCC-11-7814.docx